Skip to content

Spasticity Registry Evaluating Epidemiology, Treatment Patterns and Clinical Needs

Status
Withdrawn
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT02145650
Acronym
STRETCh
Enrollment
0
Registered
2014-05-23
Start date
2014-05-31
Completion date
2015-08-31
Last updated
2015-11-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Muscle Spasticity

Brief summary

This study will examine the epidemiology (incidence and control of a disease), burden, clinical need, and treatment patterns of spasticity in patients with a diagnosis of Cerebral Palsy (CP), Multiple Sclerosis (MS), Stroke, Spinal Cord Injury (SCI), or Traumatic Brain Injury (TBI).

Interventions

OTHERNo Intervention

There is no intervention administered in this study.

Sponsors

Allergan
Lead SponsorINDUSTRY

Study design

Observational model
CASE_ONLY
Time perspective
CROSS_SECTIONAL

Eligibility

Sex/Gender
ALL
Age
2 Years to No maximum
Healthy volunteers
No

Inclusion criteria

-Diagnosis of Cerebral Palsy (CP), Multiple Sclerosis (MS), Stroke, Spinal Cord Injury (SCI), or Traumatic Brain Injury (TBI) for a minimum of 3 months

Exclusion criteria

-Participation in a spasticity clinical trial in the past 5 years.

Design outcomes

Primary

MeasureTime frame
Investigator Assessment of Spasticity Severity using a 5-Point ScaleDay 1
Percentage of Participants with Spasticity not Receiving TreatmentDay 1
Spasticity Symptom Assessment Score using a 21-item QuestionnaireDay 1
Spasticity Impact Assessment Score using a 32-item QuestionnaireDay 1

Secondary

MeasureTime frame
Referral Patterns for Spasticity ManagementDay 1
Spasticity Screening Tool Score using a 13-item QuestionnaireDay 1
Percentage of Participants with Spasticity Receiving TreatmentDay 1

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026